Olema Pharmaceuticals Inc (OLMA) Annual Balance Sheets

Annual · GAAP · USD millions
Access OLMA quarterly Balance Sheets →
The data below summarizes Olema Pharmaceuticals Inc's balance sheet position from Dec 31 2021 to Dec 31 2025, enabling a period-by-period comparison of financial strength.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent48.30
Marketable Securities, Current SH457.14
Cash & Short-term Investments505.00
Prepaid Expense And Other Assets Current10.02
Total Current Assets515.45
Equipment/Property/Plant Net0.00
Other Assets, Noncurrent17.98
Operating Lease Right Of Use Asset1.15
Total Assets533.43
Liabilities
Accounts Payable, Current AC9.25
Other Liabilities, Current42.55
Total Current Liabilities51.80
Long-term debt3.00
Total Long-term Debt3.00
Other liabilities, Noncurrent0.07
OperatingLeaseLiabilityNoncurrent0.07
Operating Lease Liability Current1.12
Total Liabilities54.87
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock1,075.49
Retained Earnings / Accumulated Deficit-597.56
Other Equity0.62
Common Stockholder's Equity478.56
Total Stockholder's Equity478.56
Liabilities & Stockholder's Equity533.43
4 historic quarters locked

Sign in to unlock the full Olema Pharmaceuticals Inc balance sheet history.

About Olema Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-107169

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.